Fundamental dimension Equity attribute | ELMDLeader $26.37▼-1.86% Cap $218.5MP/E 19.2x QuantScore71/100 | AHCOPeer $6.02▼-2.43% Cap $820.8MP/E -3.6x QuantScore50/100 | LUNGPeer $1.83▼-2.66% Cap $78.60MP/E -1.6x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
39/100 |
71/100 |
75/100 |
Valuation Multiples, PEG & DCF upside | 69/100 | 79/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 96/100 | 19/100 | 29/100 |
Growth Revenue / earnings growth & margins | 68/100 | 4/100 | 43/100 |
Sentiment Analyst ratings, targets & revisions | 83/100 | 75/100 | 62/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 19.2x | -3.6x | -1.6x |
Forward P/E (next FY) | 18.1x | -29.7x | -1.8x |
EV / EBITDA (TTM) | 13.0x | 9.8x | -1.8x |
Price / Sales | 3.0x | 0.3x | 0.9x |
Price / Free Cash Flow | 23.6x | 8.4x | -2.6x |
PEG ratio | 0.35 | 0.12 | -0.07 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 5 / 9 | 3 / 9 |
Altman Z-Score | 13.99 (Safe) | 0.52 (Distress) | -5.82 (Distress) |
Total debt / equity | 0.00 | 1.50 | 1.43 |
Quick ratio | 4.4x | 1.0x | 3.5x |
Interest coverage | — | -0.1x | -12.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +15.3% | -0.5% | +8.0% |
Net income growth YoY | +49.9% | -178.3% | +4.2% |
Gross margin (TTM) | 78.5% | 10.4% | 77.1% |
Operating margin (FY) | 18.8% | 5.7% | -59.3% |
FCF margin (FY) | 11.4% | 6.8% | -36.4% |
5. Trailing price performancePrice change over period |
1M return | -5.3% | +8.1% | -3.7% |
3M return | -31.3% | -44.1% | +56.4% |
6M return | -0.1% | -53.0% | +44.1% |
Year to date | -9.4% | -39.6% | -17.2% |
1Y return | +8.7% | -35.8% | +11.6% |
3Y return | +156.0% | -20.4% | -79.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $14.19 -46.2% premium | $37.67 +525.7% upside | $-8.79 -580.6% premium |
Wall Street consensus target | $48.50 +83.9% · range $47.00–$50.00 | $9.83 +63.3% · range $8.00–$13.00 | $10.00 +446.4% · range $2.50–$20.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 75% Buy17% Hold8% Sell | 44% Buy44% Hold11% Sell |